Search Within

Peter Maslak

  1. "Nursing"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (15)
Groups
  1. Adult Leukemia (34)
  2. Center for Hematologic Malignancies (34)
  3. Department of Medicine (34)
  4. Hematologic Malignancies, Division of (34)
  5. Nursing (34)
  6. GSK Faculty (25)

More Groups

People
  1. David Scheinberg (21)
  2. Joseph Jurcic (14)
  3. Suzanne Chanel (13)
  4. Mark Weiss (10)
  5. Tao Dao (10)
  6. Nicole Lamanna (9)

More People

Years
  1. 2021 (2)
  2. 2019 (1)
  3. 2018 (2)
  4. 2016 (1)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publications
  1. Blood (15)
  2. Journal of Clinical Oncology (8)
  3. Leukemia (2)
  4. Science Translational Medicine (2)
  5. Transfusion (2)
  6. AMIA - Annual Fall Symposium. Proceedings (1)

More Publications

Publishers
  1. American Society of Hematology (16)
  2. American Society of Clinical Oncology (8)
  3. American Association for the Advancement of Science (2)
  4. Blackwell Publishing (2)
  5. Nature Publishing Group (2)
  6. AMIA (1)

More Publishers

Results (34)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Wudhikarn, K.; Flynn, J. R.; Rivière, I.; Gönen, M.; Wang, X.; Senechal, B.; Curran, K. J.; Roshal, M.; Maslak, P. G.; Geyer, M. B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A simplified CD34+ based preharvest prediction tool for HPC(A) collection
    Journal Article

    Jacob, R. P.; Walsh, E. M.; Maslak, P. G.; Giralt, S. A.; Avecilla, S. T.
    Transfusion (2021)

    Fulltext@MSK | Save
  • Evaluation of peripheral blood mononuclear cell collection by leukapheresis
    Journal Article

    Chen, J.; Goss, C.; Avecilla, S. T.; Hong, H.; Walsh, E.; Wuest, D.; Maslak, P.; Pessin, M. S.
    Transfusion (2019)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
    Journal Article

    Davila, M. L.; Riviere, I.; Wang, X.; Bartido, S.; Park, J.; Curran, K.; Chung, S. S.; Stefanski, J.; Borquez-Ojeda, O.; Olszewska, M.; more...
    Science Translational Medicine (2014)

    Fulltext@MSK | Save
  • Targeting the intracellular WT1 oncogene product with a therapeutic human antibody
    Journal Article

    Dao, T.; Yan, S. ; Veomett, N.; Pankov, D.; Zhou, L.; Korontsvit, T.; Scott, A.; Whitten, J.; Maslak, P.; Casey, E.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report
    Meeting Abstract

    Mathew, S.; Harnicar, S.; Halton, E.; Berman, E.; Brentjens, R. J.; Heaney, M. L.; Jurcic, J. G.; Lamanna, N.; Maslak, P. G.; Rosenblat, T. L.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save